180 Wealth Advisors, LLC Edesa Biotech, Inc. Transaction History

180 Wealth Advisors, LLC

  • $629 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022
SELL
$5.17 - $8.65 $103,400 - $173,000
-20,000 Closed
0 $0
Q3 2021

Oct 28, 2021
BUY
$4.2 - $11.92 $21,000 - $59,600
5,000 Added 33.33%
20,000 $156,000
Q2 2021

Aug 13, 2021
BUY
$4.93 - $6.69 $73,950 - $100,350
15,000 New
15,000 $70,000

About Edesa Biotech, Inc.

EDSA Quotes by TradingView
  • Ticker EDSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,462,300
  • Market Cap $33.6M
  • Description
  • Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...
More about EDSA
Track This Portfolio

Track 180 Wealth Advisors, LLC Portfolio

Follow 180 Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 180 Wealth Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email